Low hospitalization rate without severe arrhythmias: a prospective survey on 350 patients early home treated with hydroxychloroquine during COVID-19 pandemic

J Cardiovasc Med (Hagerstown). 2020 Nov;21(11):922-923. doi: 10.2459/JCM.0000000000001061.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / adverse effects
  • Arrhythmias, Cardiac* / diagnosis
  • Arrhythmias, Cardiac* / etiology
  • Azithromycin* / administration & dosage
  • Azithromycin* / adverse effects
  • Betacoronavirus
  • COVID-19
  • COVID-19 Drug Treatment
  • COVID-19 Testing
  • Clinical Laboratory Techniques / methods
  • Coronavirus Infections* / diagnosis
  • Coronavirus Infections* / drug therapy
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / physiopathology
  • Drug-Related Side Effects and Adverse Reactions / diagnosis
  • Hospitalization / statistics & numerical data*
  • Humans
  • Hydroxychloroquine* / administration & dosage
  • Hydroxychloroquine* / adverse effects
  • Italy / epidemiology
  • Outcome Assessment, Health Care
  • Pandemics*
  • Pneumonia, Viral* / diagnosis
  • Pneumonia, Viral* / drug therapy
  • Pneumonia, Viral* / epidemiology
  • Pneumonia, Viral* / physiopathology
  • SARS-CoV-2
  • Time-to-Treatment

Substances

  • Anti-Infective Agents
  • Hydroxychloroquine
  • Azithromycin